Imprinting Disorders Flashcards
(35 cards)
Name clinical features of PWS
Neonatal: Severe hypotonia. feeding difficulties. failure to thrive.
Childhood: hyperphagia. Absence of satiety. Obesity.
Mild- moderate MR. Milestone delays. Behavioural problems (tamper tantrums, stubbornness, obsessive compulsive). Hypogonadism. Short stature/small hands & feet. Almond shaped eyes/ triangular mouth.
What’s the cause of Angelmans syndrome
Paternal UPD (5%). Maternal deletion (70-75%) (UBE3A). Imprinting error (2-3%) (10-15% of these are deletions). Point mutations UBE3A (10%). No abn detected (10%).
Name clinical features of Angelmans
Severe MR, dev del by 6 months, ID. Gait ataxia. Hand flapping.
Absent speech. Microcephaly. Seizures. Characteristic EEG. Unique behaviour (inappropriate laughter, happy demeanour, fascination with water & mirrors)
What genes are expressed on the paternal allele
SNURF-SNRPN, MKRN3, MAGEL2, IPW.
Unmethylated on pat allele.
Methylated in mat allele
Where is the mat allele of UBE3A expressed
Mat UBE3A is expressed in the brain (neurons).
(Mat: unmethylated:/pat: methylated)
UBE3A is biallelically expressed in all other tissues.
How is imprinting controlled in PWS and AS
By a bipartite imprinting centre:
It executes its function amidst several allele-specific covalent Histone modifications and other chromatin features.
PWS-IC includes major promotor and exon 1 of SNURF-SNRPN.
What does SNURF-SNRPN encode
Bicistronic transcript that produces two proteins (SNURF and SNRPN), and antisense transcript, lncRNA, snoRNA and a novel RNA species called sno-lncRNA.
What does UBE3A encode
E3 ubiquitin ligase. The mRNA has 7 isoforms. The antisense transcript to UBE3A most likely regulates its imprinted expression leading to repression of the pat allele.
Disruption could affect crucial neuronal processes of protein degradation/ replacement which is crucial for development of normal synapses.
What are the common breakpoints in PWS AS
15q11-q13.
bp1-bp3 (37%) or bp2- bp3 (60%)
What’s prader Willi syndrome caused by
Maternal UPD (25%). Paternal deletion (75%) SNURF-SNRPN. Imprinting error (~1%) (10-15% of these are IC deletions).
What’s the incidence of Beckwith Wiedemann
1/13,700 livebirths.
85% sporadic; 15% familial.
Autosomal,dominant
What are the clinical features of Beckwith Wiedemann
Paediatric overgrowth disorder with variable phenotype.
Major features: pre/post natal macrosomia, macroglossia, omphalocele, visceromegaly, hemihyperplasia, development of embryonal tumours, anterior lobe creases.
Minor: neonatal hypoglycaemia, advanced bone age, mid face hypoplasia.
Describe prenatal Beckwith Wiedemann features
Polyhydromnios, premature birth, fetal macrosomia, long umbilical cord, enlarged placenta, placental mesenchymal dysplasia.
Describe the monitoring of Beckwith Wiedemann
Annual renal screen 8yrs to mid adolescence to ID nephrocalcinosis or medullary sponge kidney disease.
Abdominal ultrasound every 3 months until 8yrs old: screen for embryonal tumours.
AFP (alpha fetoprotein) concentration monitoring every 2-3 months until 4yrs old: screen heptoblastoma.
Describe Beckwith Wiedemann imprinted region
Consists of 2 independent imprinting domains separated by a non-imprinted region. iC1 (H19DMR) and IC2 (KvMDR1).
IC1: paternal: METHYLATED: IGF2 expressed.
Maternal: UNMETHLATED: H19 expressed.
IC2: paternal: UNMETHYLATED: KCNQ1OT1 expressed.
Maternal: METHYLATED: CDKN1C, KCNQ1 expressed.
Describe the causes of Beckwith Wiedemann
1) paternal UPD (20%).
2) maternal IC1: GAIN of methylation: loss H19 expression (~5%).
3) maternal IC2: LOSS of methylation: loss CDKN1C, KCNQ1 expression (~50%).
4) maternal CDKN1C LoF mutation (~5% dn, ~40% familial).
5) chromosome abnormality: paternal duplication (increase of IGF2 expression); maternal inv/t (disruption of KCNQ1). (
What are the clinical features of Russell Silver
1/100,000. IUGR, postnatal growth retardation. Normal head circumference. Limb, body, facial asymmetry (hemihypoplasia).
5th finger clinodactyly, triangular fancies (frontal bossing/ prominent forehead, small chin). Cafe au lait spots, motor, speech, cognitive delays. Feeding problems. Hypoglycaemia.
What’s are the causes of Russell Silver
1) maternal UPD11 (single cases).
2) paternal IC1: LOSS methylation: H19 expressed, IGF2 silenced (~40%).
3) maternal segmental duplications (1-2%).
4) paternal IC1 mutations (microdel/dup) (1%).
5) maternal UPD7 (possibly 7q31- MEST, CPA4, COPG2) (~10%).
6) no result (~48%).
What are the issues with ART assisted reproductive technologies
Several studies have identified high incidence of rare imprinting disorders (RSS, AS, BWS, not PWS).
Suggested the process of gamete/embryo culture could cause imprinting defect by:
1) Disrupting the process of finalising the parental imprinting which occurs later in ooctyes.
2) Disrupt maintainance of the imprint: after fertilisation there are global methylation changes in the developing embryo- culturing may expose embryos to environmental factors that disrupt the imprint.
3) medical induction of superovulation could promote the collection of immature ooctyes where maternal imprinting is incomplete.
What’s associated with imprinting of GNAS
Albright Hereditary Osteodystrophy.
Mat GNAS mut/pat UPD: Pseudohypoparathyroidism type 1a/b.
Pat GNAS mut: pseudopseudohypoparathyroidism
Discuss UPD20
Altered expression on maternal GNAS 20q13.11.
Paternal UPD20, mutation of maternal GNAS, loss of methylation of alternative promoter of maternal GNAS.
Clinical features: resistance to hormones including parathyroid- growth retardation, mild brachydactyly.
When should prenatal UPD studies be offered for UPD 14 or 15
All balanced carriers of robertsonians.
Foetus with a familial or de novo balanced rob.
Foetus with a normal karyotype with a parental carrier of a rob.
Discuss 14q32 imprinted region
Region is controlled by a paternally methylated intergenic differentially methylated region (IG-DMR).
Paternally expressed genes: PEGS: DLK1 and RTL1.
Maternally expressed genes: MEGS: MEG3 and RTLas (antisense encoding microRNA).
Describe UPD14 mat
Pre/postnatal growth retardation. Hypotonia. Joint laxity. Motor/dev delay. Early onset puberty (~8yrs). Small hands and feet. Truncal obesity.
Increase in MEGS (MEG3 and RTLas), silencing of PEGS
Differential diagnosis: PWS
